Global Albumin Market Sees Strong Growth Amid Rising Demand in Biopharmaceuticals and Drug Delivery Systems

Albumin Market Size

The global Albumin revenue was US$ 5206 million in 2022 and is forecast to a readjusted size of US$ 8186.2 million by 2029 with a CAGR of 6.6% during the forecast period (2023-2029).

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-24O15630/Global_and_India_Albumin_Market_Report_Forecast_2023_2029

Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.

Inquire for Discount: https://reports.valuates.com/request/discount/QYRE-Auto-24O15630/global-and-india-albumin

By Type
• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin

By Application
• Therapeutics
• Vaccine Ingredient
• Culture Medium Ingredient

Key Companies
CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio, CBPO, RAAS, Kedrion, Merck, LFB Group, Albumedix, Thermo Fisher Scientific

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-24O15630/global-and-india-albumin

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.